GAAP EPS loss widened to $(1.22) from $(1.10) year over year in Q2 2025 as R&D expenses rose 47.7% and G&A expenses climbed 48.8% compared to Q2 2024. VAX-31 vaccine program advanced with FDA expanded ...

This week, U.S. Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic, canceled $500 million in government-funded ...

President Donald Trump’s vaccine-bashing secretary of health and human services is canceling $500 million worth of vaccine ...

Novavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share. Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 ...

The mRNA vaccines revolutionized pandemic response and are now being explored for cancer and genetic disease treatments, ...

The Department of Health and Human Services said it is canceling nearly half a billion dollars in mRNA vaccine contracts, ...

"We should be doubling down on what works - not defunding it," said former Trump Surgeon General Jerome Adams.

HHS canceled federal funding for mRNA vaccine development. Experts said this could affect our preparedness for future pandemics and innovations like cancer vaccines.

Health-care companies fell as investors continued to retreat from formerly hot areas such as obesity-drug and vaccine makers. Shares of Novo Nordisk continued their slide despite reporting a ...

Research that helped develop mRNA vaccines won the Nobel Prize in Physiology or Medicine in 2023. Members of the scientific community are criticizing Kennedy for his decision.

President Donald Trump hailed as a “medical miracle” the mRNA vaccines developed to combat the deadly COVID-19 pandemic in ...